Abstract
Interventions to prevent mother-to-child transmission (MTCT) of HIV have become increasingly efficacious over time. Furthermore, regimens and treatment protocols have become increasingly simplified to facilitate coverage at all levels of care and reduce time-to-initiation of prophylaxis regimens. Yet, a substantial number of HIV-infected pregnant women are still not being reached by PMTCT services globally. Although a challenging prospect, we have the tools to end the transmission of HIV from mothers to babies – now is the time for communities to redouble efforts to more effectively implement PMTCT strategies to reach this critical goal.
Keywords: Antiretroviral, Breastfeeding, Guidelines, HIV, Infant, Option B+, Perinatal, Maternal, Prevention of Mother-to-Child Transmission (PMTCT), Prophylaxis.
About this chapter
Cite this chapter as:
Holly Rawizza ;Antiretroviral Therapy (ART) in Pregnant Women, Frontiers in HIV Research Current Studies in HIV Research (2016) 2: 166. https://doi.org/10.2174/9781681082554116020015
DOI https://doi.org/10.2174/9781681082554116020015 |
Print ISSN 2405-9862 |
Publisher Name Bentham Science Publisher |
Online ISSN 2405-9889 |